High Tech Pharm Dividends and Buybacks
Dividend criteria checks 1/6
High Tech Pharm is a dividend paying company with a current yield of 0.94%. Next payment date is on 10th April, 2026 with an ex-dividend date of 29th December, 2025.
Key information
0.9%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | 10 Apr 26 |
| Ex dividend date | 29 Dec 25 |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
High Tech Pharm Co., Ltd. (KOSDAQ:106190) Stock Rockets 36% But Many Are Still Ignoring The Company
Feb 10
Investor Optimism Abounds High Tech Pharm Co., Ltd. (KOSDAQ:106190) But Growth Is Lacking
Sep 02We Think High Tech Pharm (KOSDAQ:106190) Can Stay On Top Of Its Debt
Jun 11A Look At The Intrinsic Value Of High Tech Pharm Co., Ltd. (KOSDAQ:106190)
Oct 23Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?
Aug 06Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%
Jul 02There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt
Feb 23Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?
Jan 19What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?
Dec 15Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A106190 has been paying a dividend for less than 10 years.
Growing Dividend: A106190's dividend payments have increased, but the company has only paid a dividend for 2 years.
Dividend Yield vs Market
| High Tech Pharm Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A106190) | 0.9% |
| Market Bottom 25% (KR) | 1.0% |
| Market Top 25% (KR) | 3.6% |
| Industry Average (Pharmaceuticals) | 0.6% |
| Analyst forecast (A106190) (up to 3 years) | n/a |
Notable Dividend: A106190's dividend (0.94%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.01%).
High Dividend: A106190's dividend (0.94%) is low compared to the top 25% of dividend payers in the KR market (3.56%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A106190's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (10.6%), A106190's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/18 08:32 |
| End of Day Share Price | 2026/03/18 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
High Tech Pharm Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.